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
agent
Inhibition of plasma corticosterone levels by the suprachiasmatic nucleusRadioimmunoassay of vasopressin during pregnancy. Use and removal of cystylaminopeptidase inhibitorsMetabolic activity of the human ventromedial nucleus neurons in relation to sex and agingAntibodies to small transmitter molecules and peptides: production and application of antibodies to dopamine, serotonin, GABA, vasopressin, vasoactive intestinal peptide, neuropeptide Y, somatostatin and substance PIncreased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus.Human basal cortisol levels are increased in hospital as compared to home settingAbsence of a difference in the neurosecretory activity of supraoptic nucleus vasopressin neurons of neuroleptic-treated schizophrenic patients.Restricted daytime feeding attenuates reentrainment of the circadian melatonin rhythm after an 8-h phase advance of the light_dark cycleApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatusEffects of androgens and estrogens on the vasopressin and oxytocin innervation of the rat brainEstrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex, aging, and Alzheimer's diseaseAlterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depressionNovel environment induced inhibition of corticosterone secretion: physiological evidence for a suprachiasmatic nucleus mediated neuronal hypothalamo-adrenal cortex pathwayIncreased melanin concentrating hormone receptor type I in the human hypothalamic infundibular nucleus in cachexia.Restricted daytime feeding modifies suprachiasmatic nucleus vasopressin release in ratsGABA receptors in the region of the dorsomedial hypothalamus of rats are implicate in the control of melatonin and corticosterone releaseGABA release from SCN terminals is necessary for the light-induced inhibition of nocturnal melatonin release in the ratAnatomical and functional demonstration of a multisynaptic suprachiasmatic adrenal (cortex) pathwayIncreased arginine vasopressin mRNA expression in the human hypothalamus
in depression: A preliminary report.Simultaneous detection of tyrosine hydroxylase-immunoreactivity and vasopressin mRNA in neurons of the human paraventricular and supraoptic nucleusVasopressin distribution, origin and functions in the central nervous systemParaventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotropin-releasing hormone neuronsOxytocin neurotransmission in the A1 area of the brain stem induces hormonal vasopressin releaseIncreased corticotropin-releasing hormone (CRH) mRNA in the paraventricular nucleus of patients with Alzheimer's disease or depressionAlterations in the circadian rhythm of salivary melatonin begin during middle-ageVasopressin and oxytocin release in the brain; a synaptic eventSuprachiasmatic nucleus lesion increases corticosterone secretionVasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone releaseThe suprachiasmatic nucleus and the control of corticosterone secretionUnchanged amounts of vasopressin mRNA in the supraoptic and paraventricular nucleus during aging and in Alzheimer's diseaseA diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist
author
type
label
J.J. van Heerikhuize
firstName
lastName
Heerikhuize